Allergic hypersensitivity to antiretroviral drugs: etravirine, raltegravir and darunavir
PubMed

Keywords

antiretroviral drugs
side effects
allergy reactions
HAART therapy

Abstract

All antiretroviral drugs can have both short-term and long-term adverse events. The risk of specific side effects varies from drug to drug, from drug class to drug class, and from patient to patient. A better understanding of the adverse effects of antiretroviral agents is of interest not only for HIV specialists, but also for other physicians who care allergy reactions in HIV-positive patients. Each antiretroviral medication is associated with its own specific adverse effects or may cause problems only in particular circumstances. In this article some adverse allergic effects of HAART therapy in the treatment of HIV from a patient are reviewed. Our aim is to gain a working knowledge of these adverse effects, promoting the early recognition and reversal of potentially serious adverse effects, and reducing the potential for adverse drug interactions.
PubMed

References

Oelze L, Pillow T. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A case report from the emergency department. J Emerg Med 2013;44:75-78.

Harr T, French LE. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome. Med Clin North Am 2010;94:727-742.

Cacoub P, Musette P, Descamps V, Meyer O, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588- 597.

Chamizo-López FJ, Gilarranz-Luengo R, Hernández-Febles M, Pena-López MJ. Transmission of antiretroviral drug resistant strains in patients diagnosed with human immunodeficiency virus infection in Gran Canaria in the period 2009-2012. Enferm Infecc Microbiol Clin 2014;32:695-696.

Ramiro MA, Llibre JM. Legal, ethical, and economic implications of breaking down once-daily fixed-dose antiretroviral combinations into their single components for cost reduction. Enferm Infecc Microbiol Clin 2014;32:598-602.

Sánchez X, Merlano C, Cruz C. Drug rash with eosinophilia and systemic symptoms (DRESS). Rev Asoc Col Dermatol 2008;16:208-210.

Fobelo Lozano MJ. Antiretroviral therapy. Detection of adverse drug reactions from hospital admission diagnoses. Farmacia Hospitalaria 1999;23:337-342.

Moya Y, Bernal F, Rojas E, Barthel E. Pharmaceutical follow up of antirretroviral treatment in outpatients. Rev Chil Infectol 2012;29:412-419.

Sharma M, Walmsley SL. Raltegravir as antiretroviral therapy in HIV/AIDS. Expert Opin Pharmacother 2014;15:395-405.

Torres HA, Rallapalli V, Saxena A, Granwehr B, et al. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect 2014. [Epub ahead of print].

Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: From epidemiology to therapeutic challenges. AIDS 2014;28:453-465.

Nayadu SK, Balar B. Colorectal cancer screening in human immunodeficiency virus population: Are they at average risk? World J Gastrointest Oncol 2012;15:259-264.

Vajdic CM, van Leeuwen MT. What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients. Curr Opin HIV AIDS 2009;4:35-41.

Walkty A, Smith D, Lopko RN, et al. Severe skin rash associated with atazanavir. Can J Infect Dis Med Microbiol 2009;20:e10-e12.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2015 Revista Alergia México

Downloads

Download data is not yet available.